Pfizer Inc - Company Profile

Powered by

All the data and insights you need on Pfizer Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Pfizer Inc Strategy Report

  • Understand Pfizer Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and pain, women’s health, cancer, inflammation, immune disorders, and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, individual provider offices, clinics, government agencies and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. The company provides its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East. Pfizer is headquartered in New York, the US.

Gain a 360-degree view of Pfizer Inc and make more informed decisions for your business Gain a 360-degree view of Pfizer Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address 66 Hudson Boulevard East, New York, 10001-2192


Telephone 1 212 7332323

No of Employees 88,000

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange PFE (NYSE)

Revenue (2022) $58.5B -41.7% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ -93.2% (2022 vs 2021)

Market Cap* $146.4B

Net Profit Margin (2022) XYZ -88.4% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Pfizer Inc premium industry data and analytics

6,300+

Clinical Trials

Determine Pfizer Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2,300+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Pfizer Inc’s relevant decision makers and contact details.

2,000+

Catalyst Calendar

Proactively evaluate Pfizer Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1,200+

Marketed Drugs

Understand Pfizer Inc’s commercialized product portfolio to stay one step ahead of the market.

1,000+

Pipeline Drugs

Identify which of Pfizer Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1,000+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

150+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

140+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Pfizer Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

9

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Pfizer Inc (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Pfizer Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Therapy Areas: - Celebrex
Internal Medicine Active Pharmaceutical Ingredients Eliquis
Oncology Contract Manufacturing Enbrel
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Pfizer Inc portfolio and identify potential areas for collaboration Understand Pfizer Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Contracts/Agreements In February, the company entered into a partnership with UT Southwestern Medical Center to create RNA-enhanced delivery technologies for genetic medicine therapies.
2024 Contracts/Agreements In February, the company and The American Cancer Society entered into a partnership to launch the Change the Odds: Uniting to Improve Cancer Outcomes initiative.
2024 Regulatory Approval In February, the company received approval from the European Commission for the oral sphingosine 1-phosphate receptor modulator VELSIPITY (etrasimod) to treat individuals with active ulcerative colitis.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Pfizer Inc Johnson & Johnson F. Hoffmann-La Roche Ltd Merck & Co Inc AbbVie Inc
Headquarters United States of America United States of America Switzerland United States of America United States of America
City New York New Brunswick Basel Kenilworth North Chicago
State/Province New York New Jersey - New Jersey Illinois
No. of Employees 88,000 131,900 103,605 72,000 50,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Albert Bourla, Ph.D. Chairman; Chief Executive Officer Executive Board 2020 61
David M. Denton Executive Vice President; Chief Financial Officer Senior Management 2022 57
Rady A. Johnson Chief Quality & Risk Officer; Executive Vice President; Chief Compliance Officer Senior Management 2019 61
Mikael Dolsten, M.D., Ph.D. President - Research and Development; Chief Scientific Officer Senior Management 2019 64
Angela Hwang President - Global Biopharmaceuticals Business; Chief Commercial Officer Senior Management 2022 57
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Pfizer Inc key executives to enhance your sales strategy Gain insight into Pfizer Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward